OTCMKTS:PCSAProcessa Pharmaceuticals Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Processa Pharmaceuticals Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $8.50 0.00 (0.00 %) (As of 07/22/2020) Add Compare Share Today's Range$8.50Now: $8.50▼$8.5050-Day Range$6.00MA: $7.78▼$9.0052-Week Range$6.00Now: $8.50▼$21.00VolumeN/AAverage Volume343 shsMarket Capitalization$46.92 millionP/E RatioN/ADividend YieldN/ABeta-0.62 ProfileAdvanced ChartCompetitorsEarningsInstitutional OwnershipHeadlinesSocial Media Processa Pharmaceuticals, Inc., a pharmaceutical company, engages in the clinical development of drug products for the unmet medical needs. Its lead product candidate is PCS-499, an oral tablet for the treatment of necrobiosis lipoidica and radiation-induced fibrosis in head and neck cancer patients. The company is based in Hanover, Maryland.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Processa Pharmaceuticals. Previous Next 2.5 Community Rank Outperform VotesProcessa Pharmaceuticals has received 70 “outperform” votes. (Add your “outperform” vote.)Underperform VotesProcessa Pharmaceuticals has received 71 “underperform” votes. (Add your “underperform” vote.)Community SentimentProcessa Pharmaceuticals has received 50.35% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Processa Pharmaceuticals and other stocks. Vote “Outperform” if you believe PCSA will outperform the S&P 500 over the long term. Vote “Underperform” if you believe PCSA will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldProcessa Pharmaceuticals does not currently pay a dividend.Dividend GrowthProcessa Pharmaceuticals does not have a long track record of dividend growth. Previous Next 1.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Processa Pharmaceuticals insiders have not sold or bought any company stock.Percentage Held by Insiders54.60% of the stock of Processa Pharmaceuticals is held by insiders. A high percentage of insider ownership can be a sign of company health. Previous Next 0.0 Earnings and Valuation Price to Book Value per Share RatioProcessa Pharmaceuticals has a P/B Ratio of 5.82. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.70 out of 5 stars Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Pharmaceutical preparations Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:PCSA Previous SymbolOTCMKTS:HUWX CUSIPN/A CIKN/A Webwww.processapharmaceuticals.com Phone443-776-3133Debt Debt-to-Equity RatioN/A Current Ratio0.29 Quick Ratio0.29Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$1.46 per share Price / Book5.82Profitability EPS (Most Recent Fiscal Year)N/A Net Income$-3,360,000.00 Net MarginsN/A Return on Equity-42.95% Return on Assets-32.37%Miscellaneous Employees15 Outstanding Shares5,520,000Market Cap$46.92 million Next Earnings Date8/12/2020 (Estimated) OptionableNot Optionable $8.50 0.00 (0.00 %) (As of 07/22/2020) 30 days | 90 days | 365 days | Advanced Chart Receive PCSA News and Ratings via Email Sign-up to receive the latest news and ratings for PCSA and its competitors with MarketBeat's FREE daily newsletter. Processa Pharmaceuticals (OTCMKTS:PCSA) Frequently Asked Questions How has Processa Pharmaceuticals' stock been impacted by COVID-19 (Coronavirus)? Processa Pharmaceuticals' stock was trading at $9.75 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, PCSA shares have decreased by 12.8% and is now trading at $8.50. View which stocks have been most impacted by Coronavirus. When is Processa Pharmaceuticals' next earnings date? Processa Pharmaceuticals is scheduled to release its next quarterly earnings announcement on Wednesday, August 12th 2020. View our earnings forecast for Processa Pharmaceuticals. How were Processa Pharmaceuticals' earnings last quarter? Processa Pharmaceuticals Inc (OTCMKTS:PCSA) posted its quarterly earnings results on Friday, May, 15th. The company reported ($0.16) EPS for the quarter. View Processa Pharmaceuticals' earnings history. Has Processa Pharmaceuticals been receiving favorable news coverage? Media stories about PCSA stock have trended somewhat negative this week, according to InfoTrie Sentiment Analysis. The research group ranks the sentiment of media coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Processa Pharmaceuticals earned a coverage optimism score of -1.7 on InfoTrie's scale. They also gave news stories about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the company's share price in the next few days. View the latest news about Processa Pharmaceuticals. Who are some of Processa Pharmaceuticals' key competitors? Some companies that are related to Processa Pharmaceuticals include Theratechnologies (THTX), Theratechnologies (THERF), LifeVantage (LFVN), Heat Biologics (HTBX), Aptinyx (APTX), Galera Therapeutics (GRTX), GlycoMimetics (GLYC), Aytu Bioscience (AYTU), Kezar Life Sciences (KZR), NeuBase Therapeutics (NBSE), Avenue Therapeutics (ATXI), TFF Pharmaceuticals (TFFP), Cerecor (CERC), Scpharmaceuticals (SCPH) and vTv Therapeutics (VTVT). View all competitors. Who are Processa Pharmaceuticals' key executives? Processa Pharmaceuticals' management team includes the following people: Dr. David Young, Co- Founder, Chairman & CEO (Age 66)Mr. Patrick Lin, Co-Founder, Chief Bus. & Strategy Officer and Director (Age 54)Dr. Sian E. Bigora, Co-Founder & Chief Devel. Officer (Age 59)Ms. Wendy Guy, Co-Founder & Chief Admin. Officer (Age 55)Mr. James H. Stanker, Chief Financial Officer (Age 61) What is Processa Pharmaceuticals' stock symbol? Processa Pharmaceuticals trades on the OTCMKTS under the ticker symbol "PCSA." How do I buy shares of Processa Pharmaceuticals? Shares of PCSA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Processa Pharmaceuticals' stock price today? One share of PCSA stock can currently be purchased for approximately $8.50. How big of a company is Processa Pharmaceuticals? Processa Pharmaceuticals has a market capitalization of $46.92 million. Processa Pharmaceuticals employs 15 workers across the globe. What is Processa Pharmaceuticals' official website? The official website for Processa Pharmaceuticals is www.processapharmaceuticals.com. How can I contact Processa Pharmaceuticals? Processa Pharmaceuticals' mailing address is 7380 COCA COLA DRIVE SUITE 106, HANOVER MD, 21076. The company can be reached via phone at 443-776-3133 or via email at [email protected] This page was last updated on 8/4/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
